Human Gene DNM2 (ENST00000389253.9_8) from GENCODE V47lift37
  Description: dynamin 2, transcript variant 2 (from RefSeq NM_001005361.3)
Gencode Transcript: ENST00000389253.9_8
Gencode Gene: ENSG00000079805.19_14
Transcript (Including UTRs)
   Position: hg19 chr19:10,828,755-10,942,579 Size: 113,825 Total Exon Count: 21 Strand: +
Coding Region
   Position: hg19 chr19:10,828,919-10,941,723 Size: 112,805 Coding Exon Count: 21 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviewsModel Information
Methods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr19:10,828,755-10,942,579)mRNA (may differ from genome)Protein (870 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: DYN2_HUMAN
DESCRIPTION: RecName: Full=Dynamin-2; EC=3.6.5.5;
FUNCTION: Microtubule-associated force-producing protein involved in producing microtubule bundles and able to bind and hydrolyze GTP. Most probably involved in vesicular trafficking processes, in particular endocytosis. Involved in cytokinesis.
CATALYTIC ACTIVITY: GTP + H(2)O = GDP + phosphate.
SUBUNIT: Interacts with MYOF (By similarity). Interacts with SHANK1, SHANK2, SH3BP4 and NOSTRIN. Interacts with SNX9. Interacts with MYO1E (via SH3 domain).
INTERACTION: Q8N157:AHI1; NbExp=2; IntAct=EBI-346547, EBI-1049056;
SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. Cell junction, synapse. Midbody. Note=Microtubule- associated. Also found in the postsynaptic density of neuronal cells.
TISSUE SPECIFICITY: Ubiquitously expressed.
PTM: Phosphorylation at Ser-764 by CDK1 is greatly increased upon mitotic entry. It regulates cytokinesis downstream of calcineurin, and does not affect clathrin-mediated endocytosis. Dephosphorylated by Calcineurin/PP2 (By similarity).
DISEASE: Defects in DNM2 are a cause of centronuclear myopathy type 1 (CNM1) [MIM:160150]. A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.
DISEASE: Defects in DNM2 are the cause of Charcot-Marie-Tooth disease dominant intermediate type B (CMTDIB) [MIM:606482]. Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. CMTDIB is a form of Charcot-Marie-Tooth disease characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec.
DISEASE: Defects in DNM2 are the cause of Charcot-Marie-Tooth disease type 2M (CMT2M) [MIM:606482]. An axonal form of Charcot- Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced.
MISCELLANEOUS: Overexpression of CNM- and CMT-related DNM2 mutants in COS7 cells, whatever the mutated domain, led to a reduction in clathrin-mediated receptor endocytosis associated with MAPK ERK-1 and ERK-2 impairment. The membrane trafficking impairment process may represent a common pathophysiological pathway in the autosomal forms of CNM DNM2-CMT neuropathy.
SIMILARITY: Belongs to the dynamin family.
SIMILARITY: Contains 1 GED domain.
SIMILARITY: Contains 1 PH domain.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/DNM2";
WEB RESOURCE: Name=The UMD-DNM2-isoform 1 mutations database; URL="http://www.umd.be/DNM2/";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: DNM2
Diseases sorted by gene-association score: centronuclear myopathy, autosomal, modifier of* (1650), lethal congenital contracture syndrome 5* (1579), charcot-marie-tooth disease, dominant intermediate b* (1566), dnm2-related intermediate charcot-marie-tooth neuropathy* (500), centronuclear myopathy* (439), autosomal dominant intermediate charcot-marie-tooth disease type b* (400), myotubular myopathy, x-linked* (283), boomerang dysplasia (11), giant axonal neuropathy-1 (11), clivus chordoma (10), giant axonal neuropathy 2 (9), charcot-marie-tooth disease, dominant intermediate a (9), charcot-marie-tooth disease (8), intermediate charcot-marie-tooth neuropathy (8), atelosteogenesis (8), charcot-marie-tooth disease, dominant intermediate c (7), tooth disease (6), brachial plexus neuritis (6), autosomal dominant nonsyndromic deafness 20 (5), myopathy (5), urofacial syndrome 1 (5), epidermolysis bullosa simplex with muscular dystrophy (5), charcot-marie-tooth disease, axonal, type 2k (4), muscle tissue disease (2)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 56.31 RPKM in Colon - Transverse
Total median expression: 1294.56 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -83.50164-0.509 Picture PostScript Text
3' UTR -429.70856-0.502 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR022812 - Dynamin
IPR000375 - Dynamin_central
IPR001401 - Dynamin_GTPase
IPR019762 - Dynamin_GTPase_CS
IPR003130 - GED
IPR020850 - GTPase_effector_domain_GED
IPR011993 - PH_like_dom
IPR001849 - Pleckstrin_homology

Pfam Domains:
PF00169 - PH domain
PF00350 - Dynamin family
PF01031 - Dynamin central region
PF02212 - Dynamin GTPase effector domain

SCOP Domains:
50729 - PH domain-like
52540 - P-loop containing nucleoside triphosphate hydrolases

Protein Data Bank (PDB) 3-D Structure
MuPIT help
2YS1 - NMR MuPIT


ModBase Predicted Comparative 3D Structure on P50570
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0003924 GTPase activity
GO:0005515 protein binding
GO:0005525 GTP binding
GO:0008017 microtubule binding
GO:0016787 hydrolase activity
GO:0017124 SH3 domain binding
GO:0019899 enzyme binding
GO:0019901 protein kinase binding
GO:0031749 D2 dopamine receptor binding
GO:0036312 phosphatidylinositol 3-kinase regulatory subunit binding
GO:0044877 macromolecular complex binding
GO:0050699 WW domain binding
GO:0050998 nitric-oxide synthase binding

Biological Process:
GO:0000086 G2/M transition of mitotic cell cycle
GO:0000266 mitochondrial fission
GO:0002031 G-protein coupled receptor internalization
GO:0003281 ventricular septum development
GO:0003374 dynamin family protein polymerization involved in mitochondrial fission
GO:0006355 regulation of transcription, DNA-templated
GO:0006893 Golgi to plasma membrane transport
GO:0006897 endocytosis
GO:0006898 receptor-mediated endocytosis
GO:0006909 phagocytosis
GO:0007165 signal transduction
GO:0007283 spermatogenesis
GO:0009416 response to light stimulus
GO:0010592 positive regulation of lamellipodium assembly
GO:0019886 antigen processing and presentation of exogenous peptide antigen via MHC class II
GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway
GO:0030516 regulation of axon extension
GO:0031623 receptor internalization
GO:0033572 transferrin transport
GO:0035020 regulation of Rac protein signal transduction
GO:0035904 aorta development
GO:0042220 response to cocaine
GO:0043065 positive regulation of apoptotic process
GO:0044351 macropinocytosis
GO:0045429 positive regulation of nitric oxide biosynthetic process
GO:0045807 positive regulation of endocytosis
GO:0045893 positive regulation of transcription, DNA-templated
GO:0048489 synaptic vesicle transport
GO:0048812 neuron projection morphogenesis
GO:0050766 positive regulation of phagocytosis
GO:0050999 regulation of nitric-oxide synthase activity
GO:0060976 coronary vasculature development
GO:0061024 membrane organization
GO:0061025 membrane fusion
GO:0071245 cellular response to carbon monoxide
GO:0071481 cellular response to X-ray
GO:0071732 cellular response to nitric oxide
GO:1900026 positive regulation of substrate adhesion-dependent cell spreading
GO:1902856 negative regulation of non-motile cilium assembly
GO:1903351 cellular response to dopamine
GO:1903358 regulation of Golgi organization
GO:1903408 positive regulation of sodium:potassium-exchanging ATPase activity
GO:1903526 negative regulation of membrane tubulation
GO:2000370 positive regulation of clathrin-dependent endocytosis

Cellular Component:
GO:0000139 Golgi membrane
GO:0001891 phagocytic cup
GO:0001917 photoreceptor inner segment
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005768 endosome
GO:0005794 Golgi apparatus
GO:0005802 trans-Golgi network
GO:0005813 centrosome
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0005874 microtubule
GO:0005886 plasma membrane
GO:0005905 clathrin-coated pit
GO:0005925 focal adhesion
GO:0014069 postsynaptic density
GO:0016020 membrane
GO:0030027 lamellipodium
GO:0030054 cell junction
GO:0030426 growth cone
GO:0030496 midbody
GO:0030666 endocytic vesicle membrane
GO:0030670 phagocytic vesicle membrane
GO:0031410 cytoplasmic vesicle
GO:0031966 mitochondrial membrane
GO:0032587 ruffle membrane
GO:0032991 macromolecular complex
GO:0042995 cell projection
GO:0045202 synapse
GO:0045211 postsynaptic membrane
GO:0045334 clathrin-coated endocytic vesicle
GO:0048471 perinuclear region of cytoplasm
GO:0070062 extracellular exosome


-  Descriptions from all associated GenBank mRNAs
  AB209213 - Homo sapiens mRNA for dynamin 2 isoform 4 variant protein.
AK312260 - Homo sapiens cDNA, FLJ92555.
BC054501 - Homo sapiens dynamin 2, mRNA (cDNA clone MGC:57679 IMAGE:6473791), complete cds.
L36983 - Homo sapiens dynamin (DNM) mRNA, complete cds.
BC039596 - Homo sapiens dynamin 2, mRNA (cDNA clone MGC:48834 IMAGE:5722134), complete cds.
AK289831 - Homo sapiens cDNA FLJ78533 complete cds, highly similar to Homo sapiens dynamin 2 (DNM2), transcript variant 4, mRNA.
KJ896719 - Synthetic construct Homo sapiens clone ccsbBroadEn_06113 DNM2 gene, encodes complete protein.
KR711376 - Synthetic construct Homo sapiens clone CCSBHm_00023195 DNM2 (DNM2) mRNA, encodes complete protein.
KR711377 - Synthetic construct Homo sapiens clone CCSBHm_00023196 DNM2 (DNM2) mRNA, encodes complete protein.
KR711378 - Synthetic construct Homo sapiens clone CCSBHm_00023200 DNM2 (DNM2) mRNA, encodes complete protein.
KR711379 - Synthetic construct Homo sapiens clone CCSBHm_00023207 DNM2 (DNM2) mRNA, encodes complete protein.
JD458052 - Sequence 439076 from Patent EP1572962.
JD057751 - Sequence 38775 from Patent EP1572962.
JD476130 - Sequence 457154 from Patent EP1572962.
AK295929 - Homo sapiens cDNA FLJ56447 complete cds, highly similar to Dynamin-2 (EC 3.6.5.5).
AY927542 - Homo sapiens mRNA sequence.
AK023207 - Homo sapiens cDNA FLJ13145 fis, clone NT2RP3003282, highly similar to Homo sapiens dynamin (DNM) mRNA.
AK097875 - Homo sapiens cDNA FLJ40556 fis, clone THYMU2002583, highly similar to DYNAMIN 2.
DQ594929 - Homo sapiens piRNA piR-61041, complete sequence.
AK127033 - Homo sapiens cDNA FLJ45089 fis, clone BRAWH3029385, highly similar to Dynamin 2 (EC 3.6.1.50).
AK124881 - Homo sapiens cDNA FLJ42891 fis, clone BRHIP3008405, highly similar to Dynamin 2 (EC 3.6.1.50).
AK126192 - Homo sapiens cDNA FLJ44204 fis, clone THYMU3001234, highly similar to Dynamin 2 (EC 3.6.1.50).
AK094984 - Homo sapiens cDNA FLJ37665 fis, clone BRHIP2011508, highly similar to Dynamin-2 (EC 3.6.5.5).
AK097989 - Homo sapiens cDNA FLJ40670 fis, clone THYMU2020959, highly similar to Dynamin-2 (EC 3.6.5.5).
AK097967 - Homo sapiens cDNA FLJ40648 fis, clone THYMU2017878, highly similar to DYNAMIN 2.
JD131530 - Sequence 112554 from Patent EP1572962.
JD055057 - Sequence 36081 from Patent EP1572962.
LF393202 - JP 2014520813-A/31: COMPOSITIONS AND METHODS FOR TREATING SKELETAL MYOPATHY.
JD215043 - Sequence 196067 from Patent EP1572962.
JD498441 - Sequence 479465 from Patent EP1572962.
JD077535 - Sequence 58559 from Patent EP1572962.
JD432688 - Sequence 413712 from Patent EP1572962.
JD112624 - Sequence 93648 from Patent EP1572962.
JD111502 - Sequence 92526 from Patent EP1572962.
JD225821 - Sequence 206845 from Patent EP1572962.
JD422067 - Sequence 403091 from Patent EP1572962.
JD503556 - Sequence 484580 from Patent EP1572962.
JD098327 - Sequence 79351 from Patent EP1572962.
JD105397 - Sequence 86421 from Patent EP1572962.
JD270986 - Sequence 252010 from Patent EP1572962.
JD131193 - Sequence 112217 from Patent EP1572962.
JD244692 - Sequence 225716 from Patent EP1572962.
JD358071 - Sequence 339095 from Patent EP1572962.
JD555614 - Sequence 536638 from Patent EP1572962.
JD254292 - Sequence 235316 from Patent EP1572962.
JD135283 - Sequence 116307 from Patent EP1572962.
JD178099 - Sequence 159123 from Patent EP1572962.
JD413085 - Sequence 394109 from Patent EP1572962.
JD026977 - Sequence 8001 from Patent EP1572962.
JD031917 - Sequence 12941 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein P50570 (Reactome details) participates in the following event(s):

R-HSA-421831 trans-Golgi Network Coat Assembly
R-HSA-432706 trans-Golgi Network Lysosome Vesicle Destined Membrane Coat Assembly
R-HSA-421835 trans-Golgi Network Vesicle Scission
R-HSA-432707 trans-Golgi Network Lysosomal Vesicle Scission
R-HSA-203662 eNOS:Caveolin-1:NOSTRIN complex binds dynamin-2
R-HSA-2130641 Translocation of TGN-lysosome vesicle to lysosome
R-HSA-203565 eNOS:Caveolin-1:NOSTRIN:dynamin-2 complex binds N-WASP
R-HSA-196017 Dynamin is recruited to the gap junction plaque
R-HSA-8951498 Dissociation of Arf1:GDP, AP-1 Clathrin coated nonameric complex
R-HSA-8868236 BAR domain proteins recruit dynamin
R-HSA-190519 Internalization of gap junction plaques
R-HSA-177501 Endocytosis (internalization) of clathrin-coated vesicle
R-HSA-555065 Formation of clathrin coated vesicle
R-HSA-8868651 Endophilins recruit synaptojanins to the clathrin-coated pit
R-HSA-8868661 Dynamin-mediated GTP hydrolysis promotes vesicle scission
R-HSA-8868648 SYNJ hydrolyze PI(4,5)P2 to PI(4)P
R-HSA-8871194 RAB5 and GAPVD1 bind AP-2
R-HSA-8868658 HSPA8-mediated ATP hydrolysis promotes vesicle uncoating
R-HSA-8868659 Clathrin recruits auxilins to the clathrin-coated vesicle
R-HSA-8868660 Auxilin recruits HSPA8:ATP to the clathrin-coated vesicle
R-HSA-432722 Golgi Associated Vesicle Biogenesis
R-HSA-432720 Lysosome Vesicle Biogenesis
R-HSA-203641 NOSTRIN mediated eNOS trafficking
R-HSA-2132295 MHC class II antigen presentation
R-HSA-421837 Clathrin derived vesicle budding
R-HSA-196025 Formation of annular gap junctions
R-HSA-203765 eNOS activation and regulation
R-HSA-8856828 Clathrin-mediated endocytosis
R-HSA-1280218 Adaptive Immune System
R-HSA-199992 trans-Golgi Network Vesicle Budding
R-HSA-190873 Gap junction degradation
R-HSA-177504 Retrograde neurotrophin signalling
R-HSA-437239 Recycling pathway of L1
R-HSA-202131 Metabolism of nitric oxide
R-HSA-199991 Membrane Trafficking
R-HSA-168256 Immune System
R-HSA-190828 Gap junction trafficking
R-HSA-187037 Signaling by NTRK1 (TRKA)
R-HSA-373760 L1CAM interactions
R-HSA-1430728 Metabolism
R-HSA-5653656 Vesicle-mediated transport
R-HSA-157858 Gap junction trafficking and regulation
R-HSA-166520 Signaling by NTRKs
R-HSA-422475 Axon guidance
R-HSA-9006934 Signaling by Receptor Tyrosine Kinases
R-HSA-1266738 Developmental Biology
R-HSA-162582 Signal Transduction

-  Other Names for This Gene
  Alternate Gene Symbols: A8K1B6, DNM2 , DYN2, DYN2_HUMAN, E7EV30, E9PEQ4, ENST00000389253.1, ENST00000389253.2, ENST00000389253.3, ENST00000389253.4, ENST00000389253.5, ENST00000389253.6, ENST00000389253.7, ENST00000389253.8, K7ESI9, NM_001005361, P50570, Q5I0Y0, Q7Z5S3, Q9UPH4, uc318tdw.1, uc318tdw.2
UCSC ID: ENST00000389253.9_8
RefSeq Accession: NM_001005361.3
Protein: P50570 (aka DYN2_HUMAN)

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene DNM2:
cmt (Charcot-Marie-Tooth Hereditary Neuropathy Overview)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.